Drug Insights

The Synapse User's Toolkit: Tips for Searching Aspirin

6 March 2024
2 min read

Aspirin, also known as acetylsalicylic acid (ASA), is a widely used nonsteroidal anti-inflammatory drug (NSAID) that helps reduce pain, fever, and inflammation while also acting as an antithrombotic. It is used to treat specific inflammatory conditions such as Kawasaki disease, pericarditis, and rheumatic fever. Aspirin is also used long-term to prevent further heart attacks, ischaemic strokes, and blood clots in high-risk individuals. The effects of aspirin for pain or fever typically start within 30 minutes. Aspirin works similarly to other NSAIDs but also suppresses the normal functioning of platelets. Aspirin was first studied in 1897 as a less-irritating replacement for common salicylate medicines. By 1899, Bayer had named it "Aspirin" and sold it worldwide. Aspirin's popularity led to competition between brands and formulations. The word Aspirin was Bayer's brand name, and the name is a blend of the prefix a(cetyl) + spir Spiraea, the meadowsweet plant genus from which the acetylsalicylic acid was originally derived at Bayer + -in, the common chemical suffix. Click on the image below to begin the exploration journey of Aspirin through the Synapse database!

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

UK Regulators Greenlight Ariceum's Early Trial for I-123 Tagged PARP Blocker in Recurrent Glioblastoma Patients
Latest Hotspot
3 min read
UK Regulators Greenlight Ariceum's Early Trial for I-123 Tagged PARP Blocker in Recurrent Glioblastoma Patients
6 March 2024
UK regulators have approved Ariceum Therapeutics to initiate an early-stage trial with its innovative I-123 tagged PARP blocker for individuals experiencing repeated glioblastoma.
Read →
Unlock the Power of Synapse: A Guide to Searching Sucralfate
Drug Insights
2 min read
Unlock the Power of Synapse: A Guide to Searching Sucralfate
6 March 2024
Sucralfate is a medication that was first approved in Japan in February 1968 by Allergan.
Read →
Jacobio Gains U.S. Approval for IND Status of New P53 Y220C Stimulant JAB-30300
Latest Hotspot
3 min read
Jacobio Gains U.S. Approval for IND Status of New P53 Y220C Stimulant JAB-30300
6 March 2024
Jacobio Pharmaceuticals Secures U.S. Go-Ahead for Experimental P53 Y220C Stimulant JAB-30300 under Investigational New Drug Status.
Read →
How to Effectively Search for Risperidone on Synapse
Drug Insights
2 min read
How to Effectively Search for Risperidone on Synapse
6 March 2024
Risperidone, marketed under the trade name RISPERDAL®, is an atypical antipsychotic medication that was first approved by the US Food and Drug Administration (FDA) on December 29, 1993.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.